Kiniksa Pharmaceuticals, Ltd. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() ACLX
Arcellx, Inc. |
$56.66 | $3.12 B | -28.37 | 163 |
![]() BOLT
Bolt Biotherapeutics, Inc. |
$0.32 | $12.58 M | -0.2 | 52 |
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $8.19 B | -16.47 | 355 |
![]() CGEM
Cullinan Oncology, Inc. |
$7.58 | $442.42 M | -2.72 | 111 |
![]() CHRS
Coherus BioSciences, Inc. |
$0.74 | $85.83 M | 2.96 | 228 |
![]() COGT
Cogent Biosciences, Inc. |
$4.02 | $456.54 M | -2.07 | 205 |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$6.76 | $683.64 M | -6.61 | 181 |
![]() GOSS
Gossamer Bio, Inc. |
$0.78 | $179.02 M | -3.16 | 144 |
![]() GPCR
Structure Therapeutics Inc. |
$15.05 | $286.82 M | -6.42 | 163 |
![]() GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 |
![]() KRON
Kronos Bio, Inc. |
$0.78 | $47.86 M | -0.55 | 10 |
![]() KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 |
![]() KURA
Kura Oncology, Inc. |
$5.63 | $455.05 M | -2.79 | 192 |
![]() LRMR
Larimar Therapeutics, Inc. |
$1.78 | $113.33 M | -1.34 | 65 |
![]() LYRA
Lyra Therapeutics, Inc. |
$0.08 | $5.57 M | -0.06 | 30 |
![]() NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 |
![]() NUVL
Nuvalent, Inc. |
$61.99 | $4.44 B | -15.76 | 142 |
![]() NVCT
Nuvectis Pharma, Inc. |
$8.53 | $192.51 M | -7.41 | 13 |
![]() PHAT
Phathom Pharmaceuticals, Inc. |
$4.11 | $285.86 M | -0.78 | 427 |
![]() REPL
Replimune Group, Inc. |
$6.92 | $533.33 M | -2.26 | 331 |
![]() SPRO
Spero Therapeutics, Inc. |
$0.58 | $32.28 M | -0.45 | 32 |
![]() VTYX
Ventyx Biosciences, Inc. |
$0.93 | $66.26 M | -0.47 | 79 |